SUMMARY Prostacyclin is an arachidonic acid metabolite, synthesised throughout the gastrointestinal tract, which has different effects on water and electrolyte transport across a variety of mammalian gastrointestinal epithelia. Using a perfusion technique in the human jejunum of 11 healthy subjects in vivo, the effect of intravenous prostacyclin, 4 ng/kg/min, on jejunal water and solute transport from a glucose electrolyte solution was investigated. In the prostacyclin group (n=5), prostacyclin was infused intravenously from 70-150 minutes, and buffer administered iv from 0-70 and 150-210 minutes. In the buffer group (n=6), iv buffer was administered from 0-210 minutes. In the prostacyclin group, net jejunal absorption of water was inhibited from 90-120 min (p<0 05), 150-180 min (p<0.01) and 180-210 min (p<0O01), of sodium was inhibited from 90-120 min (p<0 05), 120-150 min (p<0-05), 150-180 min (p<0 01) and 180-210 min (p<O.Ol), and of chloride was inhibited from 90-120 min (p<005), 120-150 min (p<0.005), 150-180 min (p<001) and 180-210 min (p<001). Prostacyclin had no effect on net movement of glucose, potassium or bicarbonate. These results are consistent with a role for prostacyclin in the endogenous humoral regulation of water and electrolyte transport in the human jejunum.
Prostacyclin (PGI2), in common with other prostaglandins, is an arachidonic acid metabolite, which is synthesised throughout the gastrointestinal tract. 1 In tissues, arachidonic acid is released from membrane-bound phospholipids in response to a variety of physical and neurohumoral stimuli2 and is then oxidised by the enzyme cyclooxygenase to PGI2, PGE2, PGF2,,, and other metabolites.
Recent evidence has suggested that prostaglandins act as endogenous regulators of intestinal water and electrolyte transport. 4The role of PGI2 in this respect is unclear, because previous reports of its effect on water and ion transport across mammalian gastrointestinal epithelia have varied depending on the species studied and the experimental techniques used. In one study in the rat small intestine, PGI2 reduced luminal fluid accumulation ('enteropooling') and also inhibited enteropooling caused by choleragen and 16,16-dimethyl PGE2.5 Prostacyclin decreased short circuit current across human jejunal mucosa in vitro,6 which suggested that it might also jejunum and colon7 and in the guinea pig gall bladder.8
In view of these findings, the present study was done to investigate the effect of PGI2 on water and solute transport in the human jejunum in vivo.
Methods

SUBJECTS
Eleven healthy subjects (five men, six women), aged 20-40 years, gave written informed consent for the study, which was approved by the ethical committee of St Bartholomew's Hospital, London. electrolyte solution at 37°C was perfused through the infusion orifice at a rate of 15 ml/min. The solution contained (mmol/l): Na, 149; Cl, 124; HCO3, 25; glucose, 10; polyethylene glycol (PEG 4000), 2-5 g/l and 1 ,Ci/l of [14C]PEG as a non-absorbable marker. The osmolality was 290 mosmol/kg. The solution was continuously gassed throughout each experiment with 95% 02-5% Co2-After a 30 minute equilibration period, serial 10 minute aspirates were collected by siphonage. Aliquots were taken for immediate bicarbonate estimation and samples for determination of other solute concentrations were stored at -20°C before analysis.
EXPERIMENTAL DESIGN
The glucose electrolyte solution was continuously perfused intrajejunally from 0 to 210 minutes in all 11 subjects. In five of these subjects, PGI2 in buffer (0.5 ml/min) was infused via an indwelling cannula into an antecubital vein at a rate of 4 ng/kg/min from 70 to 150 minutes. The PGI2 infusion was preceded and followed by intravenous administration of buffer alone at the same rate. In the other six subjects, intravenous buffer was infused at the same rate throughout the study period. Pulse and blood pressure were recorded at 15 minute intervals throughout each experiment.
CHEMICALS
Prostacyclin was reconstituted from a freeze dried preparation of the sodium salt with glycine buffer (pH 10.5) The statistical significance of differences in intestinal transport rates between the group who received PGI2 and those subjects in whom buffer was infused throughout was assessed using the non-parametric Mann-Whitney U test.13 The paired Student's t test was used to determine the level of significance of the systemic effects of PGI2.13
Results
EFFECT OF PROSTACYCLIN ON WATER AND SOLUTE TRANSPORT
The effect of PGI2 on net jejunal water and solute transport is shown in Table. Prostacyclin caused an inhibition of net absorption of water, sodium and chloride, but had no significant effect on the net transport of potassium, bicarbonate, or glucose.
This inhibition of salt and water absorption by PGI2 persisted between 150 and 210 minutes after the discontinuation of PGI2 and showed no evidence of reversal, even in a single study which was continued to 300 minutes.
In order to confirm that these changes in water and ion transport were due to PGI2 and not to the buffer nor to a decrease in the absorptive capacity of the jejunum with time, a group of subjects, in whom buffer alone was infused intravenously from 0-210 minutes was also studied. In this group, net jejunal absorption of water, sodium and chloride also tended to decrease with time, although these differences did not achieve statistical significance (Table) . Statistical analysis was therefore carried out by comparing the change in net absorption of water, sodium and chloride with time for the PGI2 and buffer groups (Figure) . In the PGI2 group, there was a statistically significant (p<0.05) reduction in net jejunal absorption of water over the periods 90-120 and 150-210 minutes, and of sodium and chloride from 90-210 minutes.
SYSTEMIC EFFECTS OF PROSTACYCLIN
In all five subjects, PGI2 caused facial flushing, which appeared within five minutes of starting PGI2 infusion and resolved equally rapidly after its discontinuation. Mean pulse rate increased from 71±5 beats/min in the pre-PGI2 period to 91±4 beats/mim during PGI2 infusion (p<002). 21) This view has, however, been challenged by the finding that prostanoids may cause intestinal secretion at concentrations below those which normally affect cyclic AMP.6 It has therefore been suggested that prostanoids may also pronmote calcium entry across the serosal membrane into the enterocyte.2' Prostacyciin stimulates cyclic AMP production in human small intestinal mucosa, but only at unphysiologically high concentrations, being much less potent than PGE2 in this respect. 22 The inhibition of water, sodium and chloride absorption by PGI2 in the present study is consistent with a cyclic AMP-mediated mechanism, although an effect on calcium/calmodulin might also be involved. A role for the latter mechanism is suggested by the recent demonstration that PGI2 induces secretion in the rat colon and that this secretion was inhibited by the calcium channel blocker nifedipine and by the calmodulin inhibitor, trifluoperazine.23 In the human jejunum, PGI2 does not appear to be as potent a secretagogue as PGE2,4 which might reflect their relative effects on mucosal cyclic AMP production. Limitations in the dosage of PGI2, however, which can comfortably be tolerated by man25 26 and also its short half-life,14 prevent a full assessment of the magnitude of its effect on transmucosal epithelial fluid transport. The interpretation of the finding that PGI2 inhibited jejunal salt and water absorption should be tempered by the fact that a single, possibly supra-physiological, dose of PGI2 was studied.
The dose of PGI2 (4 ng/kg/min) administered in this study is of the order used therapeutically to prevent platelet aggregation in extracorporeal circulations.2 28 This dose was chosen as it may be calculated to result in local concentrations at the enterocyte in the order of magnitude of 108M, which is within the physiological range found in the intestine. Both-the buffer and PGI2 were infused via an indwelling cannula positioned in an antecubital vein, as this appears to reduce the frequency of local venous reactions, which may be because of the high pH of the buffer. 26 No such reaction was observed in the present study. Prostacyclin was administered intravenously to ensure that adequate concentrations of PGI2 were achieved at the serosal border of the enterocyte, where prostanoids act to effect secretion. Moreover, the high pH of the buffer precluded intraluminal administration of PGI2. Infusion of PGI2 caused flushing and tachycardia as previously reported.29 The persistent tachycardia after discontinuation of PGI2 has not been reported in other studies.29 These haemodynamic changes may have contributed to the prolonged inhibition of salt and water absorption observed following PGI2 infusion. Prostacyclin increases intestinal blood flow in the dog,30 and changes in the intestinal microcirculation may be important in the regulation of epithelial fluid transport.31 It is possible that the inhibition of salt and water absorption by PGI2 is simply blood flow dependent and this may explain why the human jejunum responds differently in vivo than in vitro, where PGI2 caused a 6-12% decrease in short circuit current, suggesting a stimulation of ion absorption.6 On the basis of these in vitro findings and also the anti-enteropooling effect of PGI2 in the rat small intestine,5 it has been suggested that PGI2 and PGE2 have diametrically opposed effects on intestinal water and electrolyte transport.32 The present study, however, shows the PGI2 has similar effects to PGE224 in the human jejunum in vivo. This highlights the importance of confirming, in vivo, observations made in vitro, where haemodynamic effects, amongst others, are eliminated.
One potential shortcoming in using this perfusion technique to examine the effect of PGI2 on jejunal fluid transport is that the occluding balloon might influence local intestinal prostaglandin biosynthesis.
Certainly, in the human ileum, fluid secretion occurs in response to an acute increase in intraluminal pressure,33 and the finding that indomethacin inhibits fluid secretion occurring in response to distention in the rat intestine34 suggests that the secretion is mediated by endogenous prostaglandins. While the experimental technique used in the present study did not permit measurements of intestinal prostaglandin biosynthesis, the balloon was inflated to a constant volume throughout each period in order to minimise any variations in endogenous prostaglandin synthesis in the jejunum during the studies.
Recent evidence suggests that the cyclooxygenase metabolites of arachidonic acid, mainly PGE2, mediate the fluid secretion in some diarrhoeal diseases. 35 36 The findings of the present study suggest that PGI2 may also contribute to the fluid secretion stimulated after arachidonic acid release in man. Further, in view of its localisation within the gastrointestinal tract,1 PGI2, as well as PGE2, may participate in the endogenous regulation of water and electrolyte transport in the human jejunum. 
